Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of ATS907 in POAG and Ocular Hypertension
NCT01520116Phase 2Unknown
- Sponsor
- Altheos, Inc.
- Start
- Jan 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ATS-907 in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Altheos, Inc.. Status: unknown.
02
Drugs
ATS-907
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01520116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01520116.